BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9694371)

  • 21. Biochemical and cellular characterisation of the Plasmodium falciparum M1 alanyl aminopeptidase (PfM1AAP) and M17 leucyl aminopeptidase (PfM17LAP).
    Mathew R; Wunderlich J; Thivierge K; Cwiklinski K; Dumont C; Tilley L; Rohrbach P; Dalton JP
    Sci Rep; 2021 Feb; 11(1):2854. PubMed ID: 33536500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and partial purification of a leucine aminopeptidase from Fasciola hepatica.
    Acosta D; Goñi F; Carmona C
    J Parasitol; 1998 Feb; 84(1):1-7. PubMed ID: 9488329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
    Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. M17 leucine aminopeptidase of the human malaria parasite Plasmodium vivax.
    Lee JY; Song SM; Seok JW; Jha BK; Han ET; Song HO; Yu HS; Hong Y; Kong HH; Chung DI
    Mol Biochem Parasitol; 2010 Mar; 170(1):45-8. PubMed ID: 19931315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.
    Maric S; Donnelly SM; Robinson MW; Skinner-Adams T; Trenholme KR; Gardiner DL; Dalton JP; Stack CM; Lowther J
    Biochemistry; 2009 Jun; 48(23):5435-9. PubMed ID: 19408962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.
    Burley SK; David PR; Lipscomb WN
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):6916-20. PubMed ID: 1871107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
    Taylor A; Peltier CZ; Torre FJ; Hakamian N
    Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The slow, tight binding of bestatin and amastatin to aminopeptidases.
    Wilkes SH; Prescott JM
    J Biol Chem; 1985 Oct; 260(24):13154-62. PubMed ID: 2865258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
    Yanow SK; Purcell LA; Spithill TW
    Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene synteny and chloroquine resistance in Plasmodium chabaudi.
    Hunt P; Martinelli A; Fawcett R; Carlton J; Carter R; Walliker D
    Mol Biochem Parasitol; 2004 Aug; 136(2):157-64. PubMed ID: 15478795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum.
    Dalal S; Klemba M
    J Biol Chem; 2007 Dec; 282(49):35978-87. PubMed ID: 17895246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of aminopeptidases in haemoglobin degradation in Plasmodium falciparum-infected erythrocytes.
    Gavigan CS; Dalton JP; Bell A
    Mol Biochem Parasitol; 2001 Sep; 117(1):37-48. PubMed ID: 11551630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of an aminopeptidase from Plasmodium falciparum.
    Vander Jagt DL; Baack BR; Hunsaker LA
    Mol Biochem Parasitol; 1984 Jan; 10(1):45-54. PubMed ID: 6363922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases.
    Harbut MB; Velmourougane G; Dalal S; Reiss G; Whisstock JC; Onder O; Brisson D; McGowan S; Klemba M; Greenbaum DC
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E526-34. PubMed ID: 21844374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergy of human immunodeficiency virus protease inhibitors with chloroquine against Plasmodium falciparum in vitro and Plasmodium chabaudi in vivo.
    He Z; Qin L; Chen L; Peng N; You J; Chen X
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2653-6. PubMed ID: 18443126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes.
    Rich DH; Moon BJ; Harbeson S
    J Med Chem; 1984 Apr; 27(4):417-22. PubMed ID: 6142952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schistosoma mansoni: purification and characterization of a membrane-associated leucine aminopeptidase.
    Xu YZ; Shawar SM; Dresden MH
    Exp Parasitol; 1990 Feb; 70(2):124-33. PubMed ID: 2298275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic implications of the inhibition of peptidases by amino aldehydes and bestatin.
    Frick L; Wolfenden R
    Biochim Biophys Acta; 1985 Jul; 829(3):311-8. PubMed ID: 3890953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of leucine aminopeptidase 3 suppresses invasion of ovarian cancer cells through down-regulation of fascin and MMP-2/9.
    Wang X; Shi L; Deng Y; Qu M; Mao S; Xu L; Xu W; Fang C
    Eur J Pharmacol; 2015 Dec; 768():116-22. PubMed ID: 26526349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection.
    Pulido-Cejudo G; Conway B; Proulx P; Brown R; Izaguirre CA
    Antiviral Res; 1997 Dec; 36(3):167-77. PubMed ID: 9477117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.